Herpetiform cutaneous metastases from transitional cell carcinoma of the urinary bladder: Immunohistochemical analysis

Journal of Clinical Pathology

Volumn 59, Issue 12, 2006, Pages 1331-1333

  Somani, B K ^a   Prita, D ^a   Grant, S ^a   Nabi, G ^a,b   N'Dow, J ^a  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL RADIOGRAPHY; AGED; ANAMNESIS; ARTICLE; BLADDER CARCINOMA; CANCER INVASION; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HERPETIFORM CUTANEOUS METASTASIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; SKIN METASTASIS; THORAX RADIOGRAPHY; TRANSITIONAL CELL CARCINOMA; TUMOR BIOPSY;

AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; DIAGNOSIS, DIFFERENTIAL; FATAL OUTCOME; FEMALE; HERPES ZOSTER; HUMANS; KERATINS; NEOPLASM PROTEINS; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 33845991819     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2005.031500     Document Type: Article

References (12)

1. Mueller TJ, Wu H, Greenberg RE, et al. Cutaneous metastases from genitourinary malignancies. Urology 2004;63:1021-6.
2. Rubin BP, Skarin AT, Pisick E, et al. Use of cytokeratins 7 and 20 in determining the origin of metastatic carcinoma of unknown primary, with special emphasis on lung cancer. Eur J Cancer Prev 2001;10:77-82.
3. Chang A, Cai J, Miranda G, et al. Usefulness of CA 125 as a preoperative prognostic marker for transitional cell carcinoma of the bladder. J Urol 2004;172(Pt 1):2182-6.
4. Harlamert HA, Mira J, Bejarano PA, et al. Thyroid transcription factor-1 and cytokeratins 7 and 20 in pulmonary and breast carcinoma. Acta Cytol 1998;42:1382-8.
5. Drlicek M, Bodenteich A, Urbanits S, et al. Immunohistochemical panel of antibodies in the diagnosis of brain metastases of the unknown primary. Pathol Res Pract 2004;200:727-34.
6. Lagendijk JH, Mullink H, Van Diest PJ, et al. Tracing the origin of adenocarcinomas with unknown primary using imrnunohistochemisrry: differential diagnosis between colonic and ovarian carcinomas as primary sites. Human Pathol 1998;29:491-7.
7. Bejarano PA, Nikiforov YE, Swenson ES, et al. Thyroid transcription factor-1, thyroglobulin, cytokeratin 7, and cytokeratin 20 in thyroid neoplasms. Appl Immunohistochem Mol Morphol 2000;8:189-94.
8. Cameron RI, Ashe P, O'Rourke DM, et al. A panel of immunohistochemical stains assists in the distinction between ovarian and renal clear cell carcinoma. Int J Gynecol Pathol 2003;22:272-6.
9. Kummar S, Fogarasi M, Canova A, et al. Cytokeratin 7 and 20 staining for the diagnosis of lung and colorectal adenocarcinoma. Br J Cancer 2002;86:1884-7.
10. Cid Mouteira P, Ortiz Rey JA, Anton Badiola I, et al. Coordinated expression of cytokeratin 7 and 20 in transitional carcinoma of the bladder: diagnostic usefulness. Actas Urol Esp 2002;26:279-84.
11. Ordonez NG. Transitional cell carcinomas of the ovary and bladder are immunophenotypically different. Histopathology 2000;36:433-8.
12. Pires Y, Andrade L, Cuello M, et al. Immunohistochemical flow chart to differentiate between primary adenocarcinoma and the most frequent extragynecological métastases in the ovary. Rev Med Chile 2002;130:1232-40.